Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study

BACKGROUND: Activating KRAS and BRAF mutations predict unresponsiveness to EGFR-targeting therapies in colorectal cancer (CRC), but their prognostic value needs further validation. In this study, we investigated the impact of KRAS codons 12 and 13, and BRAF mutations on survival from CRC, overall an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Wangefjord, Sakarias, Sundström, Magnus, Zendehrokh, Nooreldin, Lindquist, Kajsa Ericson, Nodin, Björn, Jirström, Karin, Eberhard, Jakob
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3846575/
https://ncbi.nlm.nih.gov/pubmed/24020794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2042-6410-4-17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items